Denali Therapeutics Inc. (DNLI)
Latest DNLI Insider Trades
About Denali Therapeutics Inc. (DNLI)
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
- SOUTH SAN FRANCISCO, CA
- 507
- 2017
- XNAS
https://www.denalitherapeutics.comSEC filings for DNLI on EDGAR
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 2,857 | $72K |
| Grant or award | 18 | 230,706 | |
| Bona-fide gift | 1 | 32,220 |
DNLI Insider Transactions (Form 4)
6027 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ryan J. Watts - Officer | Gift | Common Stock | 32,220 |
Recent DNLI Form 8-K Filings
5Recent DNLI Form 144 Notices of Proposed Sale
1A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Schuth Alexander O. | Officer | 2,857 | $72K | View on EDGAR |
DNLI Insider Trading - FAQ
What is the latest insider trade for DNLI?
Denali Therapeutics Inc. (DNLI) had 10 insider filings in the last 90 days, with the most recent on 2026-08-14. The full record for DNLI runs to 27 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying DNLI stock?
No insider purchases of DNLI were filed in the last 90 days.
How many insiders are selling DNLI stock?
1 insider sale of DNLI was filed in the last 90 days, totaling $72K.
Where can I see DNLI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks DNLI Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow DNLI insider buys?
Create a free InsiderAlpha account and press Watch on this page to add DNLI to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Ryan J. Watts view on EDGAR
- - Alexander O. Schuth view on EDGAR
- - Jay T. Flatley view on EDGAR
- - Peter S. Klein view on EDGAR
- - Steve E. Krognes view on EDGAR
- - David P. Schenkein view on EDGAR
- - Nancy Thornberry view on EDGAR
- - Hauwermeiren Timothy van view on EDGAR
- - Jennifer E. Cook view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where DNLI's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track DNLI insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
